中山广州医务代表 at Acadia Pharmaceuticals

San Lorenzo, Central, Paraguay

Acadia Pharmaceuticals Logo
Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, HealthcareIndustries

Requirements

  • 医学、药学、护理、医药市场营销等相关专业本科或以上学历
  • 至少2年以上医药销售经验
  • 外企背景
  • 生殖领域经验
  • 倾向男生
  • 学习能力及学术性强
  • 善于大客户管理能力
  • 以客户为中心
  • 行动导向
  • 毅力
  • 计划性
  • 专业技能学习
  • 追求成效
  • 道德与价值观

Responsibilities

  • 负责在市场上推广和介绍公司产品
  • 完成分配的销售任务
  • 拜访目标医院,了解医生对公司产品的看法
  • 建立与更新客户档案,与客户保持良好关系
  • 掌握市场动态,及时反馈客户关于市场趋势及产品和竞品之信息
  • 协助组织产品研讨会
  • 与现有客户保持良好关系
  • 发展潜力客户

Skills

Pharmaceutical Sales
Medical Representative
Customer Relationship Management
Hospital Visits
Doctor Engagement
Market Analysis
Sales Targets
Product Promotion
Client Management
Seminar Organization
Pharma Marketing

Acadia Pharmaceuticals

Develops therapies for neurological disorders

About Acadia Pharmaceuticals

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting areas with significant unmet medical needs, ensuring that their products address critical health challenges. Their goal is to improve the quality of life for patients suffering from these disorders while also promoting diversity, equity, and inclusion within their operations.

Dallas, TexasHeadquarters
1993Year Founded
$813.4MTotal Funding
ACQUISITIONCompany Stage
Biotechnology, HealthcareIndustries
501-1,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Employee Stock Purchase Plan
Paid Vacation
Paid Holidays
Paid Sick Leave
Paid Parental Leave
Tuition Reimbursement

Risks

Increased competition in CNS drug market may impact Acadia's market share.
Potential clinical trial delays could affect drug approval timelines.
Dependence on partnerships poses risks if collaborations face challenges or dissolve.

Differentiation

Acadia focuses on CNS disorders with unmet medical needs, like Parkinson's and Rett syndrome.
The company has a strong R&D foundation, developing innovative small molecule drugs.
Acadia's strategic partnerships enhance its research capabilities and market reach.

Upsides

Acadia's collaboration with Saniona expands its portfolio with SAN711 for neurological disorders.
Health Canada's approval of Daybue boosts Acadia's presence in the Canadian market.
The rise of personalized medicine aligns with Acadia's targeted therapy approach.

Land your dream remote job 3x faster with AI